MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.

Employees

8,000

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-06-12	15.16 $	-2.00%	961,616
26-06-11	15.47 $	+5.17%	1,413,702
26-06-10	14.71 $	-2.71%	748,654
26-06-09	15.12 $	+1.61%	799,044
26-06-08	14.88 $	+4.57%	742,286

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.47USD

Average target price

20.91USD

Spread / Average Target

+35.16%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-12 pm EDT			5-day change	1st Jan Change
15.16 ^USD	-2.00%		+6.54%	-

Jun. 03	MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion	DJ
Jun. 03	MiniMed Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended April 24, 2026	CI

Market Cap	4.34B 3.75B 3.46B 3.24B 6.07B 413B 6.16B 40.83B 15.92B 201B 16.3B 15.96B 696B	P/E Ratio 2026	-10.2x	P/E Ratio 2027 *	23.1x
Enterprise Value	3.99B 3.45B 3.18B 2.97B 5.57B 379B 5.66B 37.51B 14.62B 185B 14.98B 14.66B 639B	EV / Sales 2026	1.25x	EV / Sales 2027 *	1.19x
Free-Float	9.49%	Yield 2026 *	-	Yield 2027 *	-

Jun. 03	MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion	DJ
Jun. 03	MiniMed Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended April 24, 2026	CI
Jun. 03	MiniMed Expands Abbott Partnership to Commercialize Dual Glucose-Ketone Sensors	MT
Jun. 03	MiniMed Fiscal Q4 Loss Unchanged, Revenue Rises; Shares Up Pre-Bell	MT
Jun. 03	Earnings Flash (MMED) MiniMed Reports Q4 Revenue $837.0M, vs. FactSet Est of $827.9M	MT
Jun. 03	Medtronic beats quarterly estimates on robust demand for heart devices	RE
Jun. 03	Minimed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott	CI
May. 27	MiniMed Showcases MiniMed Flex And MiniMed Go At The American Diabetes Association Scientific Sessions	CI
May. 21	MiniMed Announces Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System	CI
May. 18	MiniMed Group, Inc. Announces Board and Committee Changes, Effective July 3, 2026	CI
May. 12	Benchmark Initiates MiniMed Group at Buy	MT
Apr. 28	MiniMed Receives Health Canada License for 780G System Software	MT
Apr. 28	Minimed Group, Inc. Announces Health Canada License for Simplera Sync Sensor, Type 2 Diabetes Indication with Minimed 780G System	CI

May. 12	Benchmark Initiates MiniMed Group at Buy	MT
Mar. 31	MiniMed Likely to Ride on Pipeline Growth, BofA Says	MT
Mar. 31	MiniMed Offers a Differentiated Diabetes Platform With Improving Growth, Margin Expansion, Morgan Stanley Says	MT
Mar. 31	BofA Securities Initiates MiniMed at Buy With $27 Price Target	MT
Mar. 31	Piper Sandler Initiates MiniMed Group at Neutral With $16 Price Target	MT

MiniMed Group, Inc. Stock

Stocks

MMED

US60365F1093

Medical Equipment, Supplies & Distribution

Valuation: MiniMed Group, Inc.

Chart: MiniMed Group, Inc.

Latest news : MiniMed Group, Inc.

Analysts' recommendations: MiniMed Group, Inc.

Press Releases: MiniMed Group, Inc.

News in other languages: MiniMed Group, Inc.

Quotes and Performance

Course Extremes

Latest insider transactions

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

Jun. 03	Minimed: Fiscal Q4 Earnings Snapshot	AQ
Jun. 03	MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott	PR
Jun. 03	MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook	PR
Jun. 03	MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott	AQ
May. 21	New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System	PR

1 day	-2.00%
1 week	+6.54%
Current month	+25.91%
1 month	+27.50%
3 months	-8.29%

1 week	14.22	15.69
1 month	10.65	15.69
Current year	10.65	20.48
1 year	10.65	20.48
3 years	10.65	20.48
5 years	10.65	20.48
10 years	10.65	20.48

Date	Insider	Type	Main position	Quantity	% Market Cap.
Mar. 24	Que Thanh Dallara	Tax	Chief Executive Officer	4,809	-
Mar. 10	Chad Spooner	Free	Chief Financial Officer	269,401	-
Mar. 10	Que Thanh Dallara	Free	Chief Executive Officer	621,563	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MINIMED GROUP, INC.	-2.00%	+6.54%	-	-	4.34B
PENUMBRA, INC.	+0.12%	-0.57%	+25.77%	-2.87%	12.52B
ASAHI INTECC CO., LTD.	-4.84%	-3.12%	+54.12%	+34.63%	6.32B
GETINGE AB	+4.08%	+0.98%	+2.72%	-20.61%	5.38B
APT MEDICAL INC.	+2.67%	+3.00%	-27.08%	+21.07%	4.16B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+2.53%	+0.08%	-29.26%	-20.95%	3.73B
NOVOCURE LIMITED	+0.40%	+3.61%	-2.31%	-59.80%	2.05B
IMPLANTICA AG	+5.23%	+0.52%	+45.21%	+192.96%	1.65B
NAKANISHI INC.	-2.11%	+2.31%	+57.77%	+2.06%	1.59B
SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD	+2.24%	-6.57%	-15.26%	-48.63%	1.28B
Average	+0.83%	+0.93%	+12.41%	+10.87%	4.3B
Weighted average by Cap.	+0.32%	+1.05%	+15.50%	+5.61%

	2026	2027 *
Net sales	3.09B 2.67B 2.46B 2.3B 4.31B 293B 4.38B 29.01B 11.31B 143B 11.59B 11.34B 495B	3.42B 2.95B 2.72B 2.55B 4.78B 325B 4.85B 32.15B 12.53B 158B 12.84B 12.56B 548B
Net income	-33.73M -29.13M -26.84M -25.13M -47.09M -3.21B -47.82M -317M -124M -1.56B -127M -124M -5.4B	172M 149M 137M 128M 240M 16.36B 244M 1.62B 630M 7.96B 646M 632M 27.56B
Net Debt	-353M -305M -281M -263M -493M -33.59B -501M -3.32B -1.29B -16.35B -1.33B -1.3B -56.61B	-284M -245M -226M -211M -396M -26.97B -402M -2.67B -1.04B -13.13B -1.06B -1.04B -45.45B